NM_005188.4:c.-79C>T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_005188.4(CBL):​c.-79C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000195 in 1,178,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000016 ( 0 hom. )

Consequence

CBL
NM_005188.4 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.18

Publications

0 publications found
Variant links:
Genes affected
CBL (HGNC:1541): (Cbl proto-oncogene) This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Jul 2016]
CBL Gene-Disease associations (from GenCC):
  • CBL-related disorder
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • juvenile myelomonocytic leukemia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BS2
High AC in GnomAd4 at 6 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005188.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBL
NM_005188.4
MANE Select
c.-79C>T
5_prime_UTR
Exon 1 of 16NP_005179.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBL
ENST00000264033.6
TSL:1 MANE Select
c.-79C>T
5_prime_UTR
Exon 1 of 16ENSP00000264033.3P22681
CBL
ENST00000634586.1
TSL:5
c.-79C>T
5_prime_UTR
Exon 1 of 18ENSP00000489218.1A0A0U1RQX8
CBL
ENST00000634840.1
TSL:5
c.-79C>T
5_prime_UTR
Exon 1 of 15ENSP00000489324.1A0A0U1RR39

Frequencies

GnomAD3 genomes
AF:
0.0000407
AC:
6
AN:
147284
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000404
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000165
AC:
17
AN:
1031156
Hom.:
0
Cov.:
14
AF XY:
0.0000195
AC XY:
10
AN XY:
511626
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
20582
American (AMR)
AF:
0.000395
AC:
5
AN:
12656
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16534
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27454
South Asian (SAS)
AF:
0.0000197
AC:
1
AN:
50750
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
28936
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3160
European-Non Finnish (NFE)
AF:
0.00000968
AC:
8
AN:
826832
Other (OTH)
AF:
0.0000678
AC:
3
AN:
44252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.540
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000407
AC:
6
AN:
147284
Hom.:
0
Cov.:
32
AF XY:
0.0000556
AC XY:
4
AN XY:
71892
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40990
American (AMR)
AF:
0.000404
AC:
6
AN:
14860
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3232
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4730
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4324
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
298
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65530
Other (OTH)
AF:
0.00
AC:
0
AN:
2024
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
CBL-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
17
DANN
Benign
0.96
PhyloP100
1.2
PromoterAI
-0.072
Neutral
Mutation Taster
=299/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886047767; hg19: chr11-119077049; API